Nexium (Esomeprazole)

Esomeprazole, the active ingredient in Nexium, is a proton pump inhibitor presented as an injection for intravenous use. It reduces gastric acid secretion and is used in the management of gastro‑oesophageal reflux disease, erosive esophagitis, peptic ulcer disease, Helicobacter pylori eradication regimens, and prevention of NSAID‑induced gastric ulcers.

GNH USA supplies Nexium as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nexium, a proton pump inhibitor, acts on the gastric acid secretion pathway to treat several acid‑related conditions. - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of esophageal irritation. - Erosive esophagitis: accelerates mucosal healing and reduces further damage. - Peptic ulcer disease: supports ulcer closure and prevents recurrence. - Helicobacter pylori eradication: enhances the effectiveness of antibiotic regimens. - Prevention of NSAID‑induced gastric ulcers: reduces risk of ulcer formation in patients requiring NSAID therapy.

Common Side Effects: - Headache: mild to moderate pain often resolving without intervention. - Diarrhea: loose stools that may be transient. - Nausea: feeling of queasiness, usually mild. - Abdominal pain: discomfort in the stomach region. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis requiring medical attention. - Severe allergic reactions (anaphylaxis): rash, swelling, difficulty breathing. - Stevens‑Johnson syndrome/toxic epidermal necrolysis: serious skin reactions. - Elevated liver enzymes: potential hepatic injury. - Hypomagnesemia: low magnesium levels with prolonged use. - Interstitial nephritis: kidney inflammation.

Before initiating therapy, consider the following precautions: - Assess renal and hepatic function: dose adjustment may be required in impairment. - Monitor serum magnesium: prolonged therapy can lead to depletion. - Evaluate for hypersensitivity: discontinue if allergic reactions occur. - Use cautiously in patients with cardiovascular disease: monitor for potential interactions. - Review concomitant medications: PPIs can affect absorption of certain drugs. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Esomeprazole may interact with several medicines, requiring attention to the level of risk. Major Interactions (Avoid): - Atazanavir: reduced antiviral exposure, may compromise HIV therapy. - Rilpivirine: decreased plasma concentrations, reducing efficacy. - Clopidogrel: diminished activation, potentially lowering antiplatelet effect. Moderate Interactions (Monitor Closely): - Digoxin: increased serum levels, monitor for toxicity. - Methotrexate: reduced clearance, watch for toxicity signs. - Warfarin: possible alteration of INR, monitor coagulation parameters.